GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+0.79%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$1.02B
AUM Growth
+$1.02B
(+0.46%)
Cap. Flow
+$2M
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
30.27%
Holding
183
New
2
Increased
49
Reduced
56
Closed
6
Top Buys
| 1 |
Blackbaud
BLKB
|
$893K |
| 2 |
John Wiley & Sons Class A
WLY
|
$632K |
| 3 |
US Bancorp
USB
|
$577K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$560K |
| 5 |
Chevron
CVX
|
$434K |
Top Sells
| 1 |
Amdocs
DOX
|
$582K |
| 2 |
Stryker
SYK
|
$505K |
| 3 |
Microsoft
MSFT
|
$420K |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$369K |
| 5 |
Goldman Sachs
GS
|
$321K |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Healthcare | 17.23% |
| 3 | Financials | 11.97% |
| 4 | Consumer Staples | 10.84% |
| 5 | Industrials | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Synopsys
SNPS
$112B
| $14.5M | 1.43% |
105,701
-598
| -0.6% | -$82.1K |
|
27
Exxon Mobil
XOM
$487B
| $14.5M | 1.42% |
204,685
-703
| -0.3% | -$49.6K |
|
28
eBay
EBAY
$41.4B
| $14.2M | 1.4% |
364,706
-1,748
| -0.5% | -$68.1K |
|
|
29
John Wiley & Sons Class A
WLY
$2.16B
| $13.7M | 1.34% |
310,687
+14,394
| +5% | +$632K |
|
30
Sanofi
SNY
$121B
| $13.6M | 1.34% |
293,739
+200
| +0.1% | +$9.27K |
|
|
UN
31
DELISTED
Unilever NV New York Registry Shares
UN
| $13M | 1.28% |
216,266
-1,123
| -0.5% | -$67.4K |
|
32
Johnson & Johnson
JNJ
$427B
| $12.5M | 1.23% |
96,912
-295
| -0.3% | -$38.2K |
|
|
RDS.B
33
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $12.5M | 1.23% |
208,157
+2,568
| +1% | +$154K |
|
34
FedEx
FDX
$54.5B
| $12.3M | 1.21% |
84,230
+1,811
| +2% | +$264K |
|
35
Trimble
TRMB
$19.2B
| $12.2M | 1.2% |
313,142
+9,040
| +3% | +$351K |
|
36
Applied Materials
AMAT
$128B
| $11.9M | 1.17% |
238,635
-367
| -0.2% | -$18.3K |
|
37
PPG Industries
PPG
$25.1B
| $11.4M | 1.13% |
96,602
+3,610
| +4% | +$428K |
|
38
Brunswick
BC
$4.15B
| $11.3M | 1.11% |
216,810
+5,534
| +3% | +$288K |
|
39
Novartis
NVS
$245B
| $10.9M | 1.07% |
125,358
+2,005
| +2% | +$174K |
|
40
Gilead Sciences
GILD
$140B
| $10.7M | 1.06% |
169,589
+3,875
| +2% | +$246K |
|
41
Unilever
UL
$155B
| $10.4M | 1.02% |
172,536
+2,560
| +2% | +$154K |
|
|
42
Chevron
CVX
$324B
| $9.97M | 0.98% |
84,076
+3,656
| +5% | +$434K |
|
43
Corning
GLW
$57.4B
| $9.48M | 0.93% |
332,222
+4,537
| +1% | +$129K |
|
|
FLIR
44
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $9.16M | 0.9% |
174,215
+903
| +0.5% | +$47.5K |
|
45
Albemarle
ALB
$9.99B
| $8.96M | 0.88% |
128,829
+4,366
| +4% | +$304K |
|
46
Cognizant
CTSH
$35.3B
| $8.62M | 0.85% |
143,108
+835
| +0.6% | +$50.3K |
|
47
Mondelez International
MDLZ
$79.5B
| $7.74M | 0.76% |
139,925
-675
| -0.5% | -$37.3K |
|
48
Thermo Fisher Scientific
TMO
$186B
| $7.32M | 0.72% |
25,118
-500
| -2% | -$146K |
|
49
Berkshire Hathaway Class A
BRK.A
$1.09T
| $6.86M | 0.68% |
22
| – | – |
|
50
Ecolab
ECL
$78.6B
| $6.4M | 0.63% |
32,295
-225
| -0.7% | -$44.6K |
|